ASKA pharmaceutical Co., Ltd.【JP:E00929】Cash flow
Market cap
P/E ratio
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | |
| Depreciation & amortization | 1,709 | 1,969 | 2,447 | 2,324 | 2,491 | 3,669 |
| Cash from operations | 5,710 | -1,349 | 12,063 | 76 | 2,504 | -492 |
| Capital expenditures | -1,945 | -2,297 | -690 | -744 | -2,350 | -2,058 |
| Cash from investing | -1,897 | -6,776 | -378 | -3,348 | -14,780 | -2,927 |
| Payments for dividends | -389 | -389 | -390 | -392 | -395 | -398 |
| Proceeds from issuance of term debt, net | 500 | 3,500 | - | - | 15,144 | 3,000 |
| Repayments of term debt | -1,058 | -58 | -808 | -750 | -1,625 | -3,048 |
| Cash from financing | -557 | 4,013 | -2,384 | -1,142 | 13,036 | -392 |